Sigrid Young

INTRODUCTION: Minimally invasive endoscopic bariatric therapies (EBTs), such as intragastric balloons (IGBs) and endoscopic sleeve gastroplasty (ESG), along with pharmacotherapy using glucagon-like peptide-1 (GLP-1) agonists, have demonstrated promising longitudinal weight loss outcomes…